Through a wealth of examples, diagrams, and real-world case studies, this groundbreaking book provides a streamlined, realistic methodology to change business continuity dramatically and shows you how you can execute it in your own organization. --
The Dream Frontier is that rare book that makes available the cumulative wisdom of a century's worth of clinical examination of dreams and then reconfigured that wisdom on the basis of research in cognitive neuroscience. Drawing on psychodynamic theorists and neuroscientific researchers with equal fluency and grace, Mark Blechner introduces the reader to a conversation of the finest minds, from Freud to Jung, from Sullivan to Erikson, from Aserinksy and Kleitman to Hobson, as the work toward an understanding of dreams and dreaming that is both scientifically credible and personally meaningful. The dream, in Blechner's elegantly conceived overview, offers itself to the dreamer as an answer to a question yet to be asked. Approached in thi open-ended manner, dreams come to reveal the meaning-making systems of the unconscious in the total absence of waking considerations of reality testing and communicability. Systems of dream interpretation arise as helpful, if inherently limited, strategies for apprehending this unconscious quest for meaning. Whereas students will appreciate Blechner's concise reviews of the various schools of dream interpretation, teachers and supervisors will value his astute reexamination of the very process of interpretating dreams, which includes the manner in which group discussion of dreams may be employed to correct for individual interpretive biases. Elegantly written, lucidly argued, deftly synooptic but never ponderous in tone, The Dream Frontier provides a fresh outlook on the century just passed along with the keys to the antechambers of the new century's reinvestigation of fundamental questions of conscious and unconscious mental life. It transcends the typical limits of interdisciplinary reportage and brings both researcher and clinician to the threshold of a new, mutually enriching exploration of the dream frontier in search of basic answers to basic questions.
Medical Liability and Treatment Relationships, Fifth Edition is the only current casebook devoted to medical liability, including medical malpractice. This book is based on Part I, “The Provider and the Patient,” from Health Care Law and Ethics, Tenth Edition, and adds additional coverage of professional licensure and regulating access to drugs, and new cases and materials covering medical malpractice. Integrating public health and financial and ethical issues, this casebook uses compelling case law, clear notes, and comprehensive background information to illuminate the complex and dynamic field of health care law. New to the Fifth Edition: New author: Nadia N. Sawicki Substantial updates to the medical malpractice chapter Challenges posed by artificial intelligence in medicine Benefits for instructors and students: Comprehensive yet concise, this casebook covers all aspects of medical liability and the treatment relationships between patient and provider. Includes cases and materials on Medical Malpractice not found in the parent book, including: Financial considerations in treatment decisions Constitutionality of damage caps Cases and notes about special discovery rules, such as prohibiting ex parte contacts with treating physicians ERISA preemption of managed care liability Additional discussion problems Integrates public policy and ethics issues from a relational perspective. Clear notes provide smooth transitions between cases and background information.
The Organic Chemistry of Drug Design and Drug Action, Third Edition, represents a unique approach to medicinal chemistry based on physical organic chemical principles and reaction mechanisms that rationalize drug action, which allows reader to extrapolate those core principles and mechanisms to many related classes of drug molecules. This new edition includes updates to all chapters, including new examples and references. It reflects significant changes in the process of drug design over the last decade and preserves the successful approach of the previous editions while including significant changes in format and coverage. This text is designed for undergraduate and graduate students in chemistry studying medicinal chemistry or pharmaceutical chemistry; research chemists and biochemists working in pharmaceutical and biotechnology industries. Updates to all chapters, including new examples and references Chapter 1 (Introduction): Completely rewritten and expanded as an overview of topics discussed in detail throughout the book Chapter 2 (Lead Discovery and Lead Modification): Sections on sources of compounds for screening including library collections, virtual screening, and computational methods, as well as hit-to-lead and scaffold hopping; expanded sections on sources of lead compounds, fragment-based lead discovery, and molecular graphics; and deemphasized solid-phase synthesis and combinatorial chemistry Chapter 3 (Receptors): Drug-receptor interactions, cation-p and halogen bonding; atropisomers; case history of the insomnia drug suvorexant Chapter 4 (Enzymes): Expanded sections on enzyme catalysis in drug discovery and enzyme synthesis Chapter 5 (Enzyme Inhibition and Inactivation): New case histories: for competitive inhibition, the epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib and Abelson kinase inhibitor, imatinib for transition state analogue inhibition, the purine nucleoside phosphorylase inhibitors, forodesine and DADMe-ImmH, as well as the mechanism of the multisubstrate analog inhibitor isoniazid for slow, tight-binding inhibition, the dipeptidyl peptidase-4 inhibitor, saxagliptin Chapter 7 (Drug Resistance and Drug Synergism): This new chapter includes topics taken from two chapters in the previous edition, with many new examples Chapter 8 (Drug Metabolism): Discussions of toxicophores and reactive metabolites Chapter 9 (Prodrugs and Drug Delivery Systems): Discussion of antibody–drug conjugates
Health Care Law and Ethics, Ninth Edition offers a relationship-oriented approach to health law—covering the essentials, as well as topical and controversial subjects. The book provides thoughtful and teachable coverage of every aspect of health care law. Current and classic cases build logically from the fundamentals of the patient/provider relationship to the role of government and institutions in health care. The book is adaptable to both survey courses and courses covering portions of the field. Key Features: New authors Nick Bagley and Glenn Cohen Incorporated anticipated changes to the Affordable Care Act More current cases and more streamlined notes, including ones on medical malpractice, bioethics, and on finance and regulation More coverage of “conscientious objection” and “big data” - Discussion of new “value based” methods of physician payment - Expanded coverage of “fraud and abuse” Current issues in public health (e.g., Ebola, Zika) and controversies in reproductive choice (e.g., Hobby Lobby) Coverage of cutting-edge genetic technologies (e.g., gene editing and mitochondrial replacement)
2.5.4.5 Local and Central Alarms -- 2.5.4.6 Emergency Planning and Disaster Recovery -- 2.5.4.7 Reputation Management -- 2.5.5 Retention -- 2.5.6 Transfer -- Table 2-1 Top 10 Most Costly Terrorist Acts by Insured Property Losses -- Table 2-2 Deadly Terrorist Act Examples by Number of Fatalities (Johnston, 2015 -- Standberry, 2012) -- Case Studies, Chapter 2 -- Discussion Questions, Chapter 2 -- References, Chapter 2 -- Appendix A: Insurance Policies Related to Terrorism Risk Management -- A.1 The Terrorism Risk Reinsurance Act and Its Successors -- A.1.1 The Nature of TRIA -- A.1.2 Coverages Provided by TRIA -- A.1.3 What TRIA Does Not Include -- A.1.4 TRIA Endorsements -- A.1.5 The Debate and the Problems with TRIA -- A.1.6 Other Options to TRIA -- A.2 Kidnap, Ransom, and Extortion (K & R) Insurance Policies -- A.2.1 Types of Insurance Companies that Provide K & R Policies -- A.2.2 The Coverages Available from K & R Contracts -- A.2.3 Contractors Owned by or Employed by K & R Companies -- A.3 Cyber Insurance and Cyber Liability Insurance -- A.3.1 Cyber Insurance Categories -- A.3.2 Current Underwriting Philosophy for Cyber Exposures -- A.3.3 Cyber Insurance Limits, Cost, and Content Examples -- References, Appendix A -- About the Authors -- Credits -- More from the Publisher
A compelling look at the origins of British socialism The Making of British Socialism provides a new interpretation of the emergence of British socialism in the late nineteenth century, demonstrating that it was not a working-class movement demanding state action, but a creative campaign of political hope promoting social justice, personal transformation, and radical democracy. Mark Bevir shows that British socialists responded to the dilemmas of economics and faith against a background of diverse traditions, melding new economic theories opposed to capitalism with new theologies which argued that people were bound in divine fellowship. Bevir utilizes an impressive range of sources to illuminate a number of historical questions: Why did the British Marxists follow a Tory aristocrat who dressed in a frock coat and top hat? Did the Fabians develop a new economic theory? What was the role of Christian theology and idealist philosophy in shaping socialist ideas? He explores debates about capitalism, revolution, the simple life, sexual relations, and utopian communities. He gives detailed accounts of the Marxists, Fabians, and ethical socialists, including famous authors such as William Morris and George Bernard Shaw. And he locates these socialists among a wide cast of colorful characters, including Karl Marx, Henry Thoreau, Leo Tolstoy, and Oscar Wilde. By showing how socialism combined established traditions and new ideas in order to respond to the changing world of the late nineteenth century, The Making of British Socialism turns aside long-held assumptions about the origins of a major movement.
In the Fifth Edition of Bioethics and Public Health Law, financial and ethical issues are integrated into a concise and engaging treatment. This book is based on Part I “The Provider and the Patient” and Part II “The Patient, Provider, and the State,” from Health Care Law and Ethics, Tenth Edition, and adds material on organ transplantation, research ethics, and other topics. The complex relationship between patients, providers, the state, and public health institutions are explored through high-interest cases, informative notes, and compelling problems. New to the Fifth Edition: Thoroughly revised coverage of: Reproductive rights and justice Public health law Extensive coverage of issues relating to COVID-19 Supreme Court decisions on abortion Discussion of emerging topics, such as: Restrictions on medical abortion, interstate travel for abortion, and conflicts with EMTALA Artificial Intelligence Cutting-edge reproductive technologies (such as mitochondrial replacement techniques, uterus transplants, and In Vitro Gametogenesis) Changes to organ allocation rules and attempts to revise “brain death” and the “dead donor rule” in organ transplantation Religious liberty questions that emerged in public health cases during the COVID-19 pandemic Benefits for instructors and students: Comprehensive yet concise, this casebook covers all aspects of bioethics and public health law. Integrates public policy and ethics issues from a relational perspective. Clear notes provide smooth transitions between cases and background information. Companion website, www.health-law.org, provides background materials, updates of important events, additional relevant topics, and links to other resources on the Internet. The book includes cases and materials on bioethics not found in the parent book, such as: Organ transplantation and allocation Research ethics Gene patents
Scientific research is fundamental to addressing issues of great importance to the development of human knowledge. Scientific research fuels advances in medicine, technology and other areas important to society and has to be credible, trustworthy and able to command confidence in the face of inevitable uncertainties. Scientific researchers must be trusted and respected when they engage with knowledge acquisition and dissemination and as ethical guardians in their education and training roles of future generations of researchers. The core values of scientific research transcend disciplinary and national boundaries and approaches to the organisation and oversight of research systems can impact significantly upon the ethics and conduct of researchers. This book draws upon legal expertise to critically analyse issues of regulation, conduct and ethics at the important interface between scientific research and regulatory and legal environments. In so doing it aims to contribute important additional perspectives to the existing literature. Case studies are engaged with to assist with the critical analysis of the current position and the consideration of future possibilities. The book will be of interest to academics in the fields of science, law and policy; science and law students; and scientific researchers at more advanced stages of their careers. Research professionals in government and the private sector and legal practitioners with interests in the regulation of research should also find the work of interest.
The entertainment industry has long been dominated by legendary screenwriter William Goldman’s “Nobody-Knows-Anything” mantra, which argues that success is the result of managerial intuition and instinct. This book builds the case that combining such intuition with data analytics and rigorous scholarly knowledge provides a source of sustainable competitive advantage – the same recipe for success that is behind the rise of firms such as Netflix and Spotify, but has also fueled Disney’s recent success. Unlocking a large repertoire of scientific studies by business scholars and entertainment economists, the authors identify essential factors, mechanisms, and methods that help a new entertainment product succeed. The book thus offers a timely alternative to “Nobody-Knows” decision-making in the digital era: while coupling a good idea with smart data analytics and entertainment theory cannot guarantee a hit, it systematically and substantially increases the probability of success in the entertainment industry. Entertainment Science is poised to inspire fresh new thinking among managers, students of entertainment, and scholars alike. Thorsten Hennig-Thurau and Mark B. Houston – two of our finest scholars in the area of entertainment marketing – have produced a definitive research-based compendium that cuts across various branches of the arts to explain the phenomena that provide consumption experiences to capture the hearts and minds of audiences. Morris B. Holbrook, W. T. Dillard Professor Emeritus of Marketing, Columbia University Entertainment Science is a must-read for everyone working in the entertainment industry today, where the impact of digital and the use of big data can’t be ignored anymore. Hennig-Thurau and Houston are the scientific frontrunners of knowledge that the industry urgently needs. Michael Kölmel, media entrepreneur and Honorary Professor of Media Economics at University of Leipzig Entertainment Science’s winning combination of creativity, theory, and data analytics offers managers in the creative industries and beyond a novel, compelling, and comprehensive approach to support their decision-making. This ground-breaking book marks the dawn of a new Golden Age of fruitful conversation between entertainment scholars, managers, and artists. Allègre Hadida, Associate Professor in Strategy, University of Cambridge
Research-proven activities that engage students in active processing of new information, leading to deeper understanding, long-term retention of subject matter, and acquisition of life-long learning skills.
Leading psychotherapists present a broad range of theoretical, philosophical, and clinical perspectives on the self-contained person who seeks therapy. With numerous enlightening case studies, they explore the characteristics of the self-contained patient--often a bright, dedicated, hardworking, and successful person who has decided to be self-reliant and to achieve without needing or acknowledging help. The experts also examine the provocations leading self-contained persons to seek therapy. This authoritative volume addresses the intricacies of working with the self-contained person, who is often competitive and ill at ease with experts, and proposes successful interventions for treating the ever-challenging and provocative self-contained patient.
This timely book emphasizes the importance of regulation in enabling and channelling innovation at a time when technology is increasingly embedded in healthcare. It considers the adequacy of current regulatory approaches, identifying apparent gaps, risks and liabilities, and discusses how these might be collectively addressed. The authors present possible solutions that balance the protection and promotion of public trust in healthcare against enabling technological progress and disruptive innovation.
The air was electric at California's Capitol. At a rally on the building steps, one speaker after another railed against a new bill to regulate parents' vaccination choices. If it passed, parents could no longer skirt California's daycare and school vaccine requirements by claiming religious or philosophical objections to vaccines. In response to attempts to eliminate these nonmedical exemptions (NMEs), Robert F. Kennedy Jr. shouted to the crowd that "parents know best" when it comes to their children's health. Bob Sears, the pediatrician author of best-seller The Vaccine Book, called on parents to "Get out there and fight for your rights!" Protestors, many of them dressed in red shirts, chanted, "My Child, My Choice." Signs amplified their message: "Force my veggies, not vaccines" and "Protect the Children, Not Big Pharma.""--
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.